Polycythemia Vera — Trials

Polycythemia Vera — Trials · CancerIndex

Clinical trials

Registered studies

181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 46
Recruiting: 25
Ph III recruiting: 7
Growth YoY: —
Industry share: 50%
Top sponsor: Massachusetts General Hospital
Termination share: 32.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (27)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02577926	The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia(Ruxo-BEAT)	active not recruiting	Phase 2	207	RWTH Aachen UniversityOTHER	1	Aug 13, 2026	clinicaltrials
NCT06985147	A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)	active not recruiting	Phase 2	60	Disc Medicine, IncINDUSTRY	1	Jul 31, 2026